Who owns Hemrajani Rekha?

No ownership or control links for Hemrajani Rekha are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Hemrajani Rekha's risk level?

WhiteIntel flags Hemrajani Rekha as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Hemrajani Rekha appear across sources?

Hemrajani Rekha is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

●

Hemrajani Rekha

Name: Hemrajani Rekha — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Hemrajani Rekha, Person, US

Low

PersonUS

View network JSON / MCPsample

Fig. 01 — Cross-source signature

/01

Key facts

Risk signal

Controls: 13 companies
Risk: Low
Jurisdiction: US

Low

Risk

Hemrajani Rekha controls or directs 13 companies (US).

/02

Control & directorships

Controlled by

None in current sources.

Directorships & controlled companies

Hemrajani Rekha
- BioAge Labs, Inc.· director· via sec_form345
- ALX ONCOLOGY HOLDINGS INC· director· via sec_form345
- BioAge Labs, Inc.· director· via SEC EDGAR
- LB PHARMACEUTICALS INC· director· via SEC EDGAR
- MAXCYTE, INC.· director· via SEC EDGAR
- ALX ONCOLOGY HOLDINGS INC· director· via SEC EDGAR
- JIYA ACQUISITION CORP.· director· via SEC EDGAR
- JIYA ACQUISITION CORP.· officer· via SEC EDGAR
- ARAVIVE, INC.· other· via SEC EDGAR
- Adverum Biotechnologies, Inc.· director· via SEC EDGAR
- ARAVIVE, INC.· officer· via SEC EDGAR
- ARAVIVE, INC.· director· via SEC EDGAR
- Arcus Biosciences, Inc.· officer· via SEC EDGAR

/ Community notesFREE

Analyst context the registries don’t carry — corrections, links, open questions on Hemrajani Rekha. Notes are community-contributed leads, not verified facts.

Loading notes…